These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 21295475

  • 1. Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists.
    Griffith DA, Hargrove DM, Maurer TS, Blum CA, De Lombaert S, Inthavongsay JK, Klade LE, Mack CM, Rose CR, Sanders MJ, Carpino PA.
    Bioorg Med Chem Lett; 2011 May 01; 21(9):2641-5. PubMed ID: 21295475
    [Abstract] [Full Text] [Related]

  • 2. Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
    Duhault J, Boulanger M, Chamorro S, Boutin JA, Della Zuana O, Douillet E, Fauchère JL, Félétou M, Germain M, Husson B, Vega AM, Renard P, Tisserand F.
    Can J Physiol Pharmacol; 2000 Feb 01; 78(2):173-85. PubMed ID: 10737680
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, McGovern RT, Hogan JB, Leahy CL, Flowers SC, Stanley JA, Ortiz AA, Poindexter GS.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):224-32. PubMed ID: 18573246
    [Abstract] [Full Text] [Related]

  • 4. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L, Rigollier P, Batzl-Hartmann C, Rüeger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, Heurich RO, Walker MW, Chiesi M, Schilling W, Hofbauer KG, Levens N.
    J Clin Invest; 1998 Dec 15; 102(12):2136-45. PubMed ID: 9854049
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of the potent, orally available, brain-penetrable arylpyrazole class of neuropeptide Y5 receptor antagonists.
    Sato N, Takahashi T, Shibata T, Haga Y, Sakuraba A, Hirose M, Sato M, Nonoshita K, Koike Y, Kitazawa H, Fujino N, Ishii Y, Ishihara A, Kanatani A, Fukami T.
    J Med Chem; 2003 Feb 27; 46(5):666-9. PubMed ID: 12593644
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor.
    Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H.
    J Pharmacol Exp Ther; 2006 May 27; 317(2):562-70. PubMed ID: 16436501
    [Abstract] [Full Text] [Related]

  • 7. Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR).
    Kaplan J, Verheijen JC, Brooijmans N, Toral-Barza L, Hollander I, Yu K, Zask A.
    Bioorg Med Chem Lett; 2010 Jan 15; 20(2):640-3. PubMed ID: 19963384
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG, Fruttarolo F, Tabrizi MA, Preti D, Romagnoli R, El-Kashef H, Moorman A, Varani K, Gessi S, Merighi S, Borea PA.
    J Med Chem; 2003 Mar 27; 46(7):1229-41. PubMed ID: 12646033
    [Abstract] [Full Text] [Related]

  • 9. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
    Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN.
    Br J Pharmacol; 1998 Oct 27; 125(3):549-55. PubMed ID: 9806339
    [Abstract] [Full Text] [Related]

  • 10. 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists.
    Saito T, Obitsu T, Kondo T, Matsui T, Nagao Y, Kusumi K, Matsumura N, Ueno S, Kishi A, Katsumata S, Kagamiishi Y, Nakai H, Toda M.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5432-45. PubMed ID: 21865047
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM, Mohamed MA, Ahmed RR, Ahmed SA.
    Eur J Med Chem; 2009 Sep 15; 44(9):3519-23. PubMed ID: 19398146
    [Abstract] [Full Text] [Related]

  • 12. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, Ishii Y, Okabe T, Fukami T, Ihara M.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):169-73. PubMed ID: 10872822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A, Kanno T, Ishihara A, Hata M, Sakuraba A, Tanaka T, Tsuchiya Y, Mase T, Fukuroda T, Fukami T, Ihara M.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):88-91. PubMed ID: 10581170
    [Abstract] [Full Text] [Related]

  • 15. Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.
    Ando M, Sato N, Nagase T, Nagai K, Ishikawa S, Takahashi H, Ohtake N, Ito J, Hirayama M, Mitobe Y, Iwaasa H, Gomori A, Matsushita H, Tadano K, Fujino N, Tanaka S, Ohe T, Ishihara A, Kanatani A, Fukami T.
    Bioorg Med Chem; 2009 Aug 15; 17(16):6106-22. PubMed ID: 19616955
    [Abstract] [Full Text] [Related]

  • 16. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
    Ducray R, Ballard P, Barlaam BC, Hickinson MD, Kettle JG, Ogilvie DJ, Trigwell CB.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):959-62. PubMed ID: 18182285
    [Abstract] [Full Text] [Related]

  • 17. Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2.
    Paruch K, Dwyer MP, Alvarez C, Brown C, Chan TY, Doll RJ, Keertikar K, Knutson C, McKittrick B, Rivera J, Rossman R, Tucker G, Fischmann TO, Hruza A, Madison V, Nomeir AA, Wang Y, Lees E, Parry D, Sgambellone N, Seghezzi W, Schultz L, Shanahan F, Wiswell D, Xu X, Zhou Q, James RA, Paradkar VM, Park H, Rokosz LR, Stauffer TM, Guzi TJ.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6220-3. PubMed ID: 17904841
    [Abstract] [Full Text] [Related]

  • 18. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition.
    Schusdziarra V, Zimmermann JP, Schick RR.
    Obes Res; 2004 Apr 15; 12(4):627-32. PubMed ID: 15090630
    [Abstract] [Full Text] [Related]

  • 19. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A, Rägo L, Harro J.
    Br J Pharmacol; 1998 Aug 15; 124(7):1507-15. PubMed ID: 9723965
    [Abstract] [Full Text] [Related]

  • 20. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL, Dolzhenko A, Kachler S, Paoletta S, Federico S, Cacciari B, Dolzhenko A, Klotz KN, Moro S, Spalluto G, Pastorin G.
    J Med Chem; 2010 Apr 22; 53(8):3361-75. PubMed ID: 20307065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.